chr7-107710182-G-A

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_000441.2(SLC26A4):​c.2218G>A​(p.Gly740Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00273 in 1,604,892 control chromosomes in the GnomAD database, including 83 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 40 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 43 hom. )

Consequence

SLC26A4
NM_000441.2 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: 5.59
Variant links:
Genes affected
SLC26A4 (HGNC:8818): (solute carrier family 26 member 4) Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a topological_domain Cytoplasmic (size 272) in uniprot entity S26A4_HUMAN there are 26 pathogenic changes around while only 8 benign (76%) in NM_000441.2
BP4
Computational evidence support a benign effect (MetaRNN=0.0029495358).
BP6
Variant 7-107710182-G-A is Benign according to our data. Variant chr7-107710182-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 43544.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-107710182-G-A is described in Lovd as [Likely_benign]. Variant chr7-107710182-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0143 (2182/152248) while in subpopulation AFR AF= 0.0497 (2066/41528). AF 95% confidence interval is 0.048. There are 40 homozygotes in gnomad4. There are 1041 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 40 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC26A4NM_000441.2 linkc.2218G>A p.Gly740Ser missense_variant Exon 19 of 21 ENST00000644269.2 NP_000432.1 O43511-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC26A4ENST00000644269.2 linkc.2218G>A p.Gly740Ser missense_variant Exon 19 of 21 NM_000441.2 ENSP00000494017.1 O43511-1
SLC26A4ENST00000492030.2 linkn.404G>A non_coding_transcript_exon_variant Exon 4 of 6 5
SLC26A4ENST00000644846.1 linkn.*120G>A non_coding_transcript_exon_variant Exon 8 of 10 ENSP00000494344.1 A0A2R8Y4W7
SLC26A4ENST00000644846.1 linkn.*120G>A 3_prime_UTR_variant Exon 8 of 10 ENSP00000494344.1 A0A2R8Y4W7

Frequencies

GnomAD3 genomes
AF:
0.0143
AC:
2182
AN:
152130
Hom.:
40
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0499
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00478
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.00955
GnomAD3 exomes
AF:
0.00369
AC:
928
AN:
251264
Hom.:
21
AF XY:
0.00281
AC XY:
382
AN XY:
135790
show subpopulations
Gnomad AFR exome
AF:
0.0500
Gnomad AMR exome
AF:
0.00182
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000131
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000273
Gnomad OTH exome
AF:
0.00278
GnomAD4 exome
AF:
0.00151
AC:
2194
AN:
1452644
Hom.:
43
Cov.:
27
AF XY:
0.00129
AC XY:
932
AN XY:
723258
show subpopulations
Gnomad4 AFR exome
AF:
0.0495
Gnomad4 AMR exome
AF:
0.00217
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000186
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000175
Gnomad4 OTH exome
AF:
0.00373
GnomAD4 genome
AF:
0.0143
AC:
2182
AN:
152248
Hom.:
40
Cov.:
32
AF XY:
0.0140
AC XY:
1041
AN XY:
74456
show subpopulations
Gnomad4 AFR
AF:
0.0497
Gnomad4 AMR
AF:
0.00477
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000323
Gnomad4 OTH
AF:
0.00945
Alfa
AF:
0.00224
Hom.:
13
Bravo
AF:
0.0165
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0502
AC:
221
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00437
AC:
530
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.000436
EpiControl
AF:
0.000296

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
Dec 17, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

May 23, 2018
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

SLC26A4: PM5, BP4, BS1, BS2 -

not specified Benign:5
Oct 18, 2017
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 14, 2016
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 16, 2010
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Gly740Ser in exon 19 of SLC26A4: This variant is not expected to have clinical s ignificance due a common occurrence in the general population (dbSNP - rs1715435 3). -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Pendred syndrome Benign:3
Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Apr 26, 2014
Counsyl
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: literature only

- -

Nov 06, 2019
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 4 Benign:1
Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Pendred syndrome;C3538946:Autosomal recessive nonsyndromic hearing loss 4 Benign:1
May 06, 2022
Fulgent Genetics, Fulgent Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.068
T;T
Eigen
Benign
-0.15
Eigen_PC
Benign
0.11
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Benign
0.43
.;T
MetaRNN
Benign
0.0029
T;T
MetaSVM
Benign
-0.85
T
MutationAssessor
Benign
0.0
N;N
PrimateAI
Benign
0.48
T
PROVEAN
Benign
0.70
N;.
REVEL
Uncertain
0.40
Sift
Benign
0.091
T;.
Sift4G
Benign
0.16
T;.
Polyphen
0.0
B;B
Vest4
0.33
MVP
0.98
MPC
0.011
ClinPred
0.023
T
GERP RS
5.5
Varity_R
0.11
gMVP
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17154353; hg19: chr7-107350627; API